New Brunswick is calling for a united front of provinces and territories to oppose Ottawa’s plan to extend the patent life on a number of popular and costly prescription medications.Murphy's current push looks to be aimed at building a united front at the provincial and territorial level. But there shouldn't be much doubt that there will be at least one national voice also working to keep prescription drug costs affordable - not just by pushing back against the latest attempt to hand out freebies to brand-name pharmaceutical manufacturers, but also by leading the charge for the universal access to prescription drugs which the provinces have already agreed to pursue.
Health Minister Mike Murphy said Thursday that generic drugs save provincial drug programs millions and he accused the federal Conservative government of bowing to the "greed" of the brand-name drug industry.
"There is only so much greed that can be supported with regard to this industry," he said in a statement in the New Brunswick legislature.
Murphy also described the move as "a cash grab" by big drug companies...
Murphy said New Brunswick spent $14.5 million last year on just three brand-name drugs for which generic versions may be delayed.
He said Ottawa’s new regulations, which would postpone some generics by at least two years, would cost the province an additional $4 million per year.
While the NDP looks to have another opportunity to build connections at the provincial and territorial level, the effect for the Cons is just the opposite. Instead, the evergreening issue also offers yet another example of how the Cons' corporate giveaways are damaging the interests of Canada's provinces. And the less shy the provinces are about making that case, the more likely they'll be able to look forward to a federal government whose goals better match their own.
(H/t to contratianna at Babble.)
No comments:
Post a Comment